Unilateral focused ultrasound pallidotomy for medication‑resistant limb dystonia
Official title: Focused Ultrasound Pallidotomy for Medication-Refractory Limb Dystonia (FUTURE Study)
Run by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · NCT07168850 · Data updated 2026-11-12
This will test whether a non‑invasive focused ultrasound procedure can reduce arm or leg dystonia symptoms in adults who haven't improved with medicines or botulinum toxin.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 34 (estimated) |
| Sponsor | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta Academic / other |
| Locations | 4 sites (Mestre, (Venice) and 3 other locations) |
| Status | Recruiting |
| Started | January 27, 2025 |
| Main results expected | February 28, 2027 |
| Study ends | February 28, 2027 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT07168850 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–80 with idiopathic or hereditary focal or segmental limb dystonia that has not improved with oral medications and botulinum toxin, who can tolerate MRI and have sufficient skull density (SDR ≥ 0.40), are ideal candidates.
✕Probably not a fit
People with acquired secondary dystonia, dementia or other neurodegenerative disease, prior DBS or brain surgery, contraindications to MRI, or low skull density (SDR < 0.40) are unlikely to benefit or are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The FUTURE trial is a prospective, randomized, double‑blind, sham‑controlled, multicenter study comparing unilateral MR‑guided focused ultrasound (MRgFUS) pallidotomy targeting the globus pallidus internus (GPi) to a sham procedure in adults with medication‑refractory limb dystonia. Thirty‑four participants aged 18–80 with idiopathic or genetic focal/segmental limb dystonia who failed oral drugs and botulinum toxin will be randomly assigned to active or sham treatment. The procedure uses MRI guidance and Exablate MRgFUS to create a millimeter‑scale lesion in the GPi while participants are awake and monitored; safety and symptom severity will be tracked over scheduled follow‑up visits. Key exclusions include secondary (acquired) dystonia, prior deep brain stimulation or other brain surgery, MRI contraindications, and low skull density ratio (SDR < 0.40).
Why it matters
Potential benefit: If successful, the procedure could reduce limb dystonia symptoms and offer a less invasive alternative to deep brain surgery for people who don't respond to medications or botulinum toxin.
How similar studies have gone: MRgFUS has established benefit for essential tremor and Parkinsonian tremor and small uncontrolled reports suggest pallidotomy may help dystonia, but randomized sham‑controlled data in limb dystonia are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18-80 years * Able and willing to consent and attend visits * Idiopathic or hereditary limb dystonia (focal, segmental, or multifocal; isolated or combined) * Refractory to oral therapy and botulinum toxin * Stable medication for ≥30 days and ≥90 days since last BoNT * Capable of communicating during Exablate procedure Exclusion Criteria: * Acquired secondary dystonia * Dementia or other neurodegenerative disorders * Any clinically significant or unstable medical condition, which, in the opinion of the principal investigator or the clinician delegated by the principal investigator, may put the participant at risk when participating in the study (e.g., unstable heart disease or coagulopathy; uncontrolled psychiatric comorbidity) * Prior deep brain stimulation or other brain surgery * Any contraindication to MRI * Skull Density Ratio (SDR) \< 0.40 * Significant brain lesions (eg brain tumor, significant white matter lesions or globus pallidus interna lesions on baseline MRI) * Pregnancy
Where it's running
-
Azienda ULSS3 Serenissima
Mestre, (Venice), Italy Recruiting -
IRCCS Centro Neurolesi "Bonino-Pulejo"
Messina, Italy Recruiting -
Fondazione IRCCS Istituto Neurologico Carlo Besta
Milan, Italy Recruiting -
Azienda Ospedaliera Ospedali Riuniti Villa Sofia
Palermo, Italy Recruiting
Study contacts
- Study coordinator: Roberto Eleopra
- Email: roberto.eleopra@istituto-besta.it
- Phone: +390223942552
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using GPi brain signals to guide DBS programming for primary dystonia
This study will test whether recording local field potentials from the globus pallidus interna with the Medtronic Percept device can help guide DBS programming and improve symptoms in adults with primary dystonia.
-
Investigating the relationship between genetic mutations and brain changes in dystonia
This study is trying to see how genetic changes linked to dystonia affect the brain in people with the condition compared to healthy individuals.
-
Ultrasound-guided versus landmark-based botulinum toxin injections for cervical dystonia
This trial will try ultrasound-guided botulinum toxin injections to see if adults with idiopathic cervical dystonia have better quality of life and similar safety compared with injections done using anatomical landmarks.
-
Neuromodulation effects on laryngeal dystonia
This study is testing if a brain stimulation treatment can help people with laryngeal dystonia improve their voice and overall quality of life.
-
Brain network patterns in focal dystonia
Researchers will use MRI scans and blood tests to try to find brain and genetic differences in adults with focal dystonia, their unaffected relatives, and healthy volunteers.
-
Using Xeomin to treat focal hand dystonia
This study is testing if injections of Xeomin can help people with focal hand dystonia feel better compared to a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.